Spots Global Cancer Trial Database for Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)
Official Title: Phase II Study of Novel Epothilone (BMS-247550) in Patients With MBC Who Are Refractory to an Anthracycline, a Taxane, and Capecitabine
Study ID: NCT00080262
Interventions
Study Description
Brief Summary: The purpose of this research study is to assess the response rate of the investigational drug BMS-247550 (Ixabepilone) in women with metastatic breast cancer who are refractory to an anthracycline, a taxane, and capecitabine.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Local Institution, La Verne, California, United States
Local Institution, Meriden, Connecticut, United States
Local Institution, Jacksonville, Florida, United States
Local Institution, Baltimore, Maryland, United States
Local Institution, Boston, Massachusetts, United States
Local Institution, New York, New York, United States
Local Institution, Asheville, North Carolina, United States
Local Institution, Charlotte, North Carolina, United States
Local Institution, Pittsburgh, Pennsylvania, United States
Local Institution, Providence, Rhode Island, United States
Local Institution, Chattanooga, Tennessee, United States
Local Institution, Jackson, Tennessee, United States
Local Institution, Knoxville, Tennessee, United States
Local Institution, Nashville, Tennessee, United States
Local Institution, Houston, Texas, United States
Local Institution, San Antonio, Texas, United States
Local Institution, Salt Lake City, Utah, United States
Local Institution, Buenos Aires, , Argentina
Local Institution, Santa Fe, , Argentina
Local Institution, Montreal, Quebec, Canada
Local Institution, Besancon Cedex, , France
Local Institution, Bobigny, , France
Local Institution, Clermont-Ferrand, , France
Local Institution, Dijon Cedex, , France
Local Institution, Lyon, , France
Local Institution, Marseille Cedex 9, , France
Local Institution, Vandoeuvre Les Nancy, , France
Local Institution, Frankfurt Hoechst, , Germany
Local Institution, Frankfurt, , Germany
Local Institution, Merida, Yucatan, Mexico
Local Institution, Chihuahua, , Mexico
Local Institution, Distrito Federal, , Mexico
Local Institution, Amsterdam, , Netherlands
Local Institution, Leiden, , Netherlands
Local Institution, Oslo, , Norway
Local Institution, Trondheim, , Norway
Local Institution, Port Elizabeth, Eastern Cape, South Africa
Local Institution, Fichardtpark, Free State, South Africa
Local Institution, Pretoria, Gauteng, South Africa
Local Institution, Overport, Kwa Zulu Natal, South Africa
Local Institution, Panorama, Western Cape, South Africa
Local Institution, Helsingborg, , Sweden
Local Institution, Lund, , Sweden
Local Institution, Malmo, , Sweden
Local Institution, Stockholm, , Sweden
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
